ZYUS (ZYUS) News
Follow ZYUS (ZYUS) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 4 public stories across 3 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
ZYUS Life Sciences Corporation (ZYUS) Sets Sept. 30 for Phase 2a Topline Data
ZYUS Life Sciences expects to announce topline Phase 2a UTOPIA-1 results on Sept. 30, 2026, and named Wayne Brownlee Audit Committee Chair while John L. Knowles serves as Interim CFO.Material DetailsContext by AI Analyst
NEWS | Sep 25, 2026, 03:36 AM UTC
L
ZYUS Life Sciences Corporation Announces Planned Release Date for Phase 2a Clinical Trial Results, Annual General Meeting Results and Change in Audit Committee Chair
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/SASKATOON, SK, Sept. 24, 2026 /CNW/ -- ZYUS Life Sciences Corporation (the "ZYUS" and or "Company") (TSXV:ZYUS), a clinic
NEWS | Sep 25, 2026, 03:36 AM UTC
L
ZYUS Life Sciences Corporation Provides General Business Update and Announces Changes in Executive Leadership
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/SASKATOON, SK, Sept. 15, 2026 /CNW/ -- ZYUS Life Sciences Corporation (the "ZYUS" or "Company") (TSXV:ZYUS), a clinical-s
NEWS | Sep 15, 2026, 11:02 AM UTC
L
ZYUS Life Sciences Corporation Announces Closing of Fifth Tranche of Secured Loan Financing
ZYUS Life Sciences Corporation Announces Closing of Fif
EQUITY | Jul 03, 2026, 03:10 AM UTC